Literature DB >> 16336514

Long QT syndrome: reduced repolarization reserve and the genetic link.

D M Roden1.   

Abstract

Marked QT prolongation and torsades de pointes can occur not only in the congenital long QT syndromes (LQTSs) but also as a consequence of environmental stimuli, notably administration of certain drugs. A key feature of this 'acquired' form of the LQTS has been its unpredictable nature. That is, although risk factors have been identified in series of patients, they have not been terribly useful in addressing risk in an individual patient. Normal cardiac repolarization depends critically on the interplay of multiple ion currents, and these provide some redundancy, or 'reserve', to protect against excessive QT prolongation by drugs. We have proposed that lesions in these repolarizing mechanisms can remain subclinical but nevertheless increase risk on drug exposure, and have termed this situation 'reduced repolarization reserve'. The evidence in support of this concept is presented, and the known and potential contributions by genetic variants to risk is examined. Assessing variability in susceptibility to acquired LQTS provides a framework for analysis of other complex gene-environment interactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16336514     DOI: 10.1111/j.1365-2796.2005.01589.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  114 in total

1.  Role of the transient outward potassium current in the genesis of early afterdepolarizations in cardiac cells.

Authors:  Zhenghang Zhao; Yuanfang Xie; Hairuo Wen; Dandan Xiao; Charelle Allen; Nadezhda Fefelova; Wen Dun; Penelope A Boyden; Zhilin Qu; Lai-Hua Xie
Journal:  Cardiovasc Res       Date:  2012-06-01       Impact factor: 10.787

2.  Common genetic variants, QT interval, and sudden cardiac death in a Finnish population-based study.

Authors:  Peter A Noseworthy; Aki S Havulinna; Kimmo Porthan; Annukka M Lahtinen; Antti Jula; Pekka J Karhunen; Markus Perola; Lasse Oikarinen; Kimmo K Kontula; Veikko Salomaa; Christopher Newton-Cheh
Journal:  Circ Cardiovasc Genet       Date:  2011-04-21

Review 3.  HERG potassium channel regulation by the N-terminal eag domain.

Authors:  Ahleah S Gustina; Matthew C Trudeau
Journal:  Cell Signal       Date:  2012-04-13       Impact factor: 4.315

4.  Dynamics of early afterdepolarization-mediated triggered activity in cardiac monolayers.

Authors:  Marvin G Chang; Connie Y Chang; Enno de Lange; Linmiao Xu; Brian O'Rourke; Hrayr S Karagueuzian; Leslie Tung; Eduardo Marbán; Alan Garfinkel; James N Weiss; Zhilin Qu; M Roselle Abraham
Journal:  Biophys J       Date:  2012-06-19       Impact factor: 4.033

5.  Systems pharmacology of arrhythmias.

Authors:  Seth I Berger; Avi Ma'ayan; Ravi Iyengar
Journal:  Sci Signal       Date:  2010-04-20       Impact factor: 8.192

Review 6.  Drug- and non-drug-associated QT interval prolongation.

Authors:  Charlotte van Noord; Mark Eijgelsheim; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

Review 7.  Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes.

Authors:  Charles Antzelevitch
Journal:  Europace       Date:  2007-09       Impact factor: 5.214

Review 8.  Perspective: a dynamics-based classification of ventricular arrhythmias.

Authors:  James N Weiss; Alan Garfinkel; Hrayr S Karagueuzian; Thao P Nguyen; Riccardo Olcese; Peng-Sheng Chen; Zhilin Qu
Journal:  J Mol Cell Cardiol       Date:  2015-03-11       Impact factor: 5.000

9.  Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.

Authors:  John D Zeuli; John W Wilson; Lynn L Estes
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

10.  Inhibition of cardiac hERG potassium channels by tetracyclic antidepressant mianserin.

Authors:  Daniel Scherer; Katharina von Löwenstern; Edgar Zitron; Eberhard P Scholz; Ramona Bloehs; Sven Kathöfer; Dierk Thomas; Alexander Bauer; Hugo A Katus; Christoph A Karle; Claudia Kiesecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.